Budget Express 2026

co-presented by

  • JIO BlackRock
HomeNewsDishmanpharmaceuticalschemicals

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Divis Laboratories may slip to Rs 750, Gail may test Rs 485-500: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com feels that Divis Laboratories may slip to Rs 750.

  • Exit Dishman Pharmaceuticals: Sharmila Joshi

    Sharmila Joshi of sharmilajoshi.com advises exiting Dishman Pharmaceuticals.

  • Bull's Eye: Buy GSPL, Gayatri Projects, Natco Pharma, REC, Dredging Corp

    Ashish Kyal of Waves Strategy Advisors advises buying Natco Pharma with a target of Rs 965.

  • Buy STC, Ceat, Dishman Pharma: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com suggests buying STC, Ceat and Dishman Pharma.

  • Here are fundamental trading ideas from Anand Tandon

    In an interview to CNBC-TV18’s Prashant Nair and Ekta Batra, Anand Tandon, a Market Expert shared his readings and outlook on market and specific stocks.

  • Buy Shriram Transport Finance Corporation, UltraTech Cement, State Bank of India: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com suggests buying Shriram Transport Finance Corporation, UltraTech Cement and State Bank of India.

  • Buy Colgate, Dishman Pharma, Future Cons; sell EIL: Thakkar

    Mitessh Thakkar of miteshthacker.com is of the view that one can buy Colgate Palmolive, Dishman Pharmaceuticals and Future Consumer and sell Engineers India and Glenmark Pharma.

  • Like BPCL, Dishman Pharma, Dish TV; V-Guard may hit Rs 275: Gaba

    Prakash Gaba of prakashgaba.com likes BPCL, Dishman Pharma, Dish TV and Bharat Financial Inclusion while he feels tthat V-Guard may hit Rs 275.

  • Bull's Eye: Buy Reliance Infra, Nalco, Exide, Arvind, Tata Chem

    Shahina Mukadam, Independent Market Expert is of the view that one may buy Dishman Pharma with a target of Rs 245.

  • Bull's Eye: Buy Wockhardt, HCC, Jet, Siemens, PNB, REC, JSPL

    Vijay Chopra of Enoch Ventures suggests buying Jet Airways with a target of Rs 400.

  • Sell Bharti Infratel, TCS; buy Dishman Pharma: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one may sell Bharti Infratel and Tata Consultancy Services.

  • Bull's Eye: Buy BoI, Titan, Divis Lab, Jindal Steel, KCP, IFCI

    Kunal Saraogi of Equityrush recommends buying Titan Company with a target of Rs 400 and Federal Bank with a target of Rs 87.

  • Top buzzing midcap stocks to trade on February 2

    Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have - M&M, Tata Motors, Bajaj Auto, CCL Prodcuts, Dishman Pharma, Shree Renuka Sugars, Chennai Petro, MRPL & Cholamandalam Investment.

  • Buy Biocon, IDBI Bank, Dishman Pharma, HPCL: Mitesh Thacker

    Mitesh Thacker of miteshthacker.com recommends buying Biocon, IDBI Bank, Dishman Pharma and HPCL.

  • Buy MOIL, NTPC, Cairn India, Dishman Pharma: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one may buy MOIL, NTPC, Cairn India, Fortis Healthcare and Dishman Pharma.

  • Buy Colgate, Aarti Industries, Dishman Pharma: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one can buy Colgate Palmolive, Aarti Industries and Dishman Pharma.

  • Stay Invested in Dishman Pharma, target Rs 280: Rajat Bose

    Rajat Bose of rajatkbose.com is of the view that one may stay Invested in Dishman Pharma.

  • Buy Dishman Pharma, HDFC, Eicher Motors: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one can buy Dishman Pharma, HDFC and Eicher Motors.

  • Sell Yes Bank, Asian Paints; buy Dishman Pharma: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one can sell Yes Bank and Asian Paints and buy Dishman Pharma.

  • Sell Bharti Infratel, Bajaj Auto; buy Dishman Pharma: Wagle

    Sandeep Wagle of powermywealth.com is of the view that one can sell Bharti Infratel and Bajaj Auto and buy Dishman Pharma.

  • Bull's Eye: Buy Alembic, NMDC, PC Jewellers; sell HDIL

    Sumeet Jain of Destimoney Securities is of the view that one may buy Alembic with a target of Rs 42.80.

  • Sell Ceat, Century Textiles; buy Dishman Pharma: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one can sell Ceat and Century Textiles and buy Dishman Pharma.

  • Bull's Eye: Buy REC, Apollo Tyres, AB Nuvo; sell JSW Steel, PFC

    Vishal Malkan of malkansview.com recommends selling Voltas with a target of Rs 375 and Jet Airways with a target of Rs 460.

  • Ceat may test Rs 1500, says Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com feels that Ceat may test Rs 1500 and Kirloskar Oil Engines may move top Rs 420.

  • Buy Balrampur Chini, Edelweiss Financial, Dishman Pharma: Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one can buy Balrampur Chini, Edelweiss Financial and Dishman Pharmaceuticals.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347